3652 results for «291»
3652 results
Complication cases - Best case submissions
06 Dec 2023 – From GulfPCR-GIM 2023
Benefit from a selection of 6 clinical cases whose complications are particularly interesting to discuss, including pericardial effusion following circumflex artery intervention, or Rota burr incarceration, to perfect your knowledge and gain tips and tricks to manage them better when you, in turn, come up against...
How should I treat my female patients?
07 Dec 2023 – From GulfPCR-GIM 2023
This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...
Five most impactful trials in 2023
02 Jan 2024 – From GulfPCR-GIM 2023
Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...
Cracking new horizons across all calcium morphologies
07 Dec 2023 – From GulfPCR-GIM 2023
Watch this session to learn all about the intravascular lithotripsy (IVL) mechanism for treating calcified lesions. Discover practical advice and techniques for implementing IVL in challenging calcified lesions and the safe utilization of IVL in left main bifurcations.
Ultra-low contrast techniques in complex and high-risk coronary interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore this session to gain insights into reducing operator reliance on contrast in PCI for enhanced safety and quality, particularly in complex scenarios. Discover essential tips, tricks, and specialized tools tailored for ultra-low-contrast PCI. Additionally, immerse yourself in a practical, step-by-step example through a recorded ultra-low-contrast...
Complex PCI in high bleeding risk patients, the way forward!
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.
Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.
OCT-guided PCI for a patient with calcified lesion
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to gain insights into the significance of actionable intracoronary imaging in the patient treatment journey and acquire knowledge on adopting procedural strategies. Learn about the effective utilisation of orbital atherectomy for plaque modification and the impact of DES platforms in the management of...
Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)
07 Nov 2024
Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Author
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Author

Author